119 results
Page 4 of 6
8-K
EX-99.2
ww0390fb0etvp
13 May 21
TELA Bio Announces First Quarter 2021 Financial Results
4:17pm
8-K
tm3u2nhia53o5euh
4 May 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
zd2md wwfauj9atbs5z
29 Mar 21
Advancing Soft Tissue Reconstruction Investor Presentation January 2021
4:05pm
8-K
EX-99.1
5amyahs
24 Mar 21
TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results
4:05pm
8-K
EX-99.1
tzcc7apct86nmrmu0c
14 Jan 21
TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020
4:05pm
S-3
EX-1.2
xifckl2b
18 Dec 20
Shelf registration
4:48pm
8-K
EX-99.1
osbm 0we2thvl
17 Nov 20
Advancing Soft Tissue Reconstruction Investor Presentation November 2020
7:00am
8-K
EX-99.1
1807hw43zdedlsuz
12 Nov 20
TELA Bio Announces Third Quarter 2020 Financial Results
7:00am
8-K
EX-99.1
2trq2vk
25 Sep 20
Other Events
7:24am
8-K
EX-99.1
z4peecfv96x47amk
12 Aug 20
TELA Bio Announces Second Quarter 2020 Financial Results
4:10pm
8-K
EX-99.2
d4vzh5 b0
12 Aug 20
TELA Bio Announces Second Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
beik5
9 Jul 20
TELA Bio Announces Interim Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair
6:05am
8-K
EX-99.2
bwro6ze mepeftbm7w
30 Jun 20
TELA Bio Announces Pricing of Public Offering of Common Stock
4:16pm
8-K
EX-99.1
vtw30qf3aeu9e gr
30 Jun 20
TELA Bio Announces Pricing of Public Offering of Common Stock
4:16pm
424B4
ybvfdk5
26 Jun 20
Prospectus supplement with pricing info
4:05pm